Arcutis Biotherapeutics Inc (ARQT)
9.20
+0.08
(+0.88%)
USD |
NASDAQ |
May 17, 16:00
9.12
-0.08
(-0.87%)
After-Hours: 20:00
Arcutis Biotherapeutics Free Cash Flow: -198.32M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -198.32M |
| December 31, 2023 | -247.48M |
| September 30, 2023 | -262.42M |
| June 30, 2023 | -309.03M |
| March 31, 2023 | -304.32M |
| December 31, 2022 | -281.00M |
| September 30, 2022 | -261.78M |
| June 30, 2022 | -212.15M |
| March 31, 2022 | -185.96M |
| Date | Value |
|---|---|
| December 31, 2021 | -175.62M |
| September 30, 2021 | -156.38M |
| June 30, 2021 | -149.16M |
| March 31, 2021 | -139.06M |
| December 31, 2020 | -113.35M |
| September 30, 2020 | -97.49M |
| June 30, 2020 | -74.42M |
| March 31, 2020 | -56.92M |
| December 31, 2019 | -43.13M |
Free Cash Flow Range, Past 5 Years
-309.03M
Minimum
Jun 2023
-43.13M
Maximum
Dec 2019
-181.56M
Average
-180.79M
Median
Free Cash Flow Benchmarks
| AdaptHealth Corp | 53.22M |
| Prestige Consumer Healthcare Inc | 239.38M |
| Pfizer Inc | 5.106B |
| Adverum Biotechnologies Inc | -92.55M |
| Karuna Therapeutics Inc (DELISTED) | -388.74M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -31.60M |
| Cash from Investing (Quarterly) | -28.70M |
| Cash from Financing (Quarterly) | 161.76M |
| Free Cash Flow Per Share (Quarterly) | -0.2846 |
| Free Cash Flow to Equity (Quarterly) | -32.61M |
| Free Cash Flow to Firm (Quarterly) | -24.05M |
| Free Cash Flow Yield | -26.36% |